.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Army
Farmers Insurance
Medtronic
Mallinckrodt
Accenture
Healthtrust
US Department of Justice
Chubb
Fish and Richardson
AstraZeneca

Generated: December 14, 2017

DrugPatentWatch Database Preview

Flucytosine - Generic Drug Details

« Back to Dashboard

What are the generic sources for flucytosine and what is the scope of flucytosine patent protection?

Flucytosine
is the generic ingredient in two branded drugs marketed by Valeant, Novel Labs Inc, Sigmapharm Labs Llc, and West-ward Pharms Int, and is included in four NDAs. Additional information is available in the individual branded drug profile pages.

There are six drug master file entries for flucytosine. Nine suppliers are listed for this compound.

Pharmacology for flucytosine

Medical Subject Heading (MeSH) Categories for flucytosine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Novel Labs IncFLUCYTOSINEflucytosineCAPSULE;ORAL204652-001Jul 7, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Novel Labs IncFLUCYTOSINEflucytosineCAPSULE;ORAL204652-002Jul 7, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
West-ward Pharms IntFLUCYTOSINEflucytosineCAPSULE;ORAL206550-002Oct 17, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
West-ward Pharms IntFLUCYTOSINEflucytosineCAPSULE;ORAL206550-001Oct 17, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Sigmapharm Labs LlcFLUCYTOSINEflucytosineCAPSULE;ORAL201566-001Jun 28, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Sigmapharm Labs LlcFLUCYTOSINEflucytosineCAPSULE;ORAL201566-002Jun 28, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
ValeantANCOBONflucytosineCAPSULE;ORAL017001-002Approved Prior to Jan 1, 1982ABRXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
ValeantANCOBONflucytosineCAPSULE;ORAL017001-001Approved Prior to Jan 1, 1982ABRXYesNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Johnson and Johnson
US Army
Boehringer Ingelheim
McKinsey
Accenture
QuintilesIMS
Covington
Queensland Health
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot